Tadalafil Tablet
Product Images NDC 70518-3931

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 70518-3931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
This is a description for a medication called Tadalafil. It is available in tablet form with a strength of 20 mg. The quantity provided is 12 tablets. It is a prescription-only medication. The NDC (National Drug Code) number for this product is 70518-3931-00. The medication is manufactured by Salce in Cranbury, NJ. The expiration date and lot number are not available in the text. The source NDC is 43547-0990-06. The medication should be stored at a temperature between 20-25°C (58-77°F), with excursions permitted to 15.30°C (59-86°F), as per USP guidelines. It has been repackaged by RemedyRepack Inc., located in Indiana, PA. Their contact number is 724-465-8762. The text also advises keeping this medication out of the reach of children.*
FDA Label Image

Ab0f57c0-figure-01 (Ab0f57c0 Figure 01)

Ab0f57c0-figure-01 (Ab0f57c0 Figure 01)
FDA Label Image

Ab0f57c0-figure-02 (Ab0f57c0 Figure 02)

Ab0f57c0-figure-02 (Ab0f57c0 Figure 02)
FDA Label Image

Ab0f57c0-figure-03 (Ab0f57c0 Figure 03)

Ab0f57c0-figure-03 (Ab0f57c0 Figure 03)
Not available.*
FDA Label Image

Ab0f57c0-figure-04 (Ab0f57c0 Figure 04)

Ab0f57c0-figure-04 (Ab0f57c0 Figure 04)
This text appears to be a table or graph showing the percentage without clinical worsening over time for different doses of Tadalafil tablets (40 mg and 20 mg) compared to a placebo. It also indicates the time to clinical worsening in days.*
FDA Label Image

Figure 1 (Image 01)

Figure 1 (Image 01)
FDA Label Image

Figure 2 (Image 02)

Figure 2 (Image 02)
FDA Label Image

Figure3 (Image 03)

Figure3 (Image 03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.